We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
51 hedge funds and large institutions have $22M invested in Zevra Therapeutics in 2021 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
115,661% more capital invested
Capital invested by funds: $19K → $22M (+$22M)
2,450% more funds holding
Funds holding: 2 → 51 (+49)
111% more call options, than puts
Call options by funds: $19.3M | Put options by funds: $9.14M
8.26% more ownership
Funds ownership: 0% → 8.26% (+8.3%)
Holders
51
Holders Change
+49
Holders Change %
+2,450%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
49
Increased
1
Reduced
–
Closed
–
Calls
$19.3M
Puts
$9.14M
Net Calls
+$10.2M
Net Calls Change
+$10.2M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.14M |
| 2 |
Millennium Management
New York
|
+$1.86M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.72M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.55M |
| 5 |
Jane Street
New York
|
+$1.39M |
Top Sellers
No sellers this quarter
